-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Heron Therapeutics, Inc. /De/ quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2021 to Q3 2024.
- Heron Therapeutics, Inc. /De/ Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.03 USD/shares, a 82.4% increase year-over-year.
- Heron Therapeutics, Inc. /De/ Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -0.12 USD/shares, a 86.7% increase year-over-year.
- Heron Therapeutics, Inc. /De/ annual Earnings Per Share, Basic for 2023 was -0.8 USD/shares, a 52.1% increase from 2022.
- Heron Therapeutics, Inc. /De/ annual Earnings Per Share, Basic for 2022 was -1.67 USD/shares, a 25.4% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)